HLA-DRB5 antibody (AA 43-70) (FITC)
Quick Overview for HLA-DRB5 antibody (AA 43-70) (FITC) (ABIN1902459)
Target
See all HLA-DRB5 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 43-70
-
Specificity
- This HLA-DRB5 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 43-70 amino acids from the Central region of human HLA-DRB5.
-
Purification
- Affinity purified
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Approved: ELISA, IHC, WB
Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, no preservatives added
-
Preservative
- Without preservative
-
Handling Advice
- Aliquot to avoid repeated freezing and thawing.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Short term: store at 4°C. Long term: aliquot and store -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.
-
Expiry Date
- 6 months
-
-
- HLA-DRB5 (Major Histocompatibility Complex, Class II, DR beta 5 (HLA-DRB5))
-
Alternative Name
- HLA-DRB5
-
Background
-
Name/Gene ID: HLA-DRB5
Synonyms: HLA-DRB5, DR-9, DR beta-5, Dw2, HLA-DRB, Human leucocyte antigen DRB5, MHC class II antigen DRB1*9, MHC class II HLA beta chain, MHC HLA-DR-beta chain, Leukocyte antigen class II, DR2-beta-2, DR9, MHC class II antigen DRB5 -
Gene ID
- 3127
-
Pathways
- TCR Signaling, Positive Regulation of Peptide Hormone Secretion, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Target
-